New chat

Home
Prompt library
NEW
AI alerts
Watchlists
Projects
Filings & transcripts
Your files
Feed
Connectors
Personalization

You're signed outSign in or to get full access.

Research
VIR
Earnings

VB

Vir Biotechnology (VIR)·Earnings Reports

Vir Biotechnology Q4 2025 earnings results — Astellas partnership and VIR-5500 Phase 1 data drive 53% after-hours surge

Q4 2025

View earnings summary and analysis

Q3 2025

View earnings summary and analysis

Q2 2025

View earnings summary and analysis

Q1 2025

View earnings summary and analysis

Q4 2024

View earnings summary and analysis

Analyst Coverage

Research analysts covering Vir Biotechnology.

Recent News about Vir Biotechnology

Vir Biotechnology Surges 55% on $1.7 Billion Astellas Deal for Prostate Cancer T-Cell Engager

Deals & Capital Markets

Vir Biotechnology Surges 55% on $1.7 Billion Astellas Deal for Prostate Cancer T-Cell Engager